HIGHLIGHTS
- who: Huihuan Wu et al. from the Department of Gastroenterology, Guangdong Provincial People`s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China School of Medicine, South China University of Technology, Guangzhou, China have published the research: Investigating the Mechanisms of Bisdemethoxycurcumin in Ulcerative Colitis: Network Pharmacology and Experimental Verification, in the Journal: Molecules 2023,Molecular 28, 68 of 21/Dec/2022
- what: The aim of this study was to determine the core target and potential mechanism of action of bisdemethoxycurcumin as a therapy for ulcerative colitis. Taken together, the research shows that the PI3K/Akt . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.